Agilent reported $1.88B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Agilent USD 1.88B 43M Jun/2026
Align Technology USD 1.02B 40M Sep/2026
Bio Techne USD 299.71M 21.49M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 836M 62M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Henry Schein USD 3.47B 10M Sep/2026
Illumina USD 1.17B 10M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Mettler Toledo International USD 1.09B 60M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Quidel USD 618.9M 12M Sep/2026
Repligen USD 209M 5M Sep/2026
Revvity USD 729M 680K Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Waters USD 1.77B 130M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026